Resumen
Background: There has rarely been any reporting on health-related quality of life (HRQOL) of patients with HIV/AIDS in developing countries. Objectives: To estimate the health utilities of people with HIV/AIDS in Bogotá, Columbia. Methods: A cross-sectional survey was conducted for 181 patients receiving antiretroviral therapy from an outpatient HIV/AIDS clinic in Bogotá. The five-level version of the EuroQol five-dimensional questionnaire (EQ-5D-5L) and the EuroQol visual analogue scale (EQ-VAS) were used to estimate HRQOL scores. To derive utilities on the basis of the EQ-5D-5L, the Spanish value set was used. Subgroup analyses were performed according to sex, age, the Centers for Disease Control and Prevention classification, and CD4 cell count. Results: The mean utility of the EQ-5D-5L was estimated at 0.85 0.21 and the EQ-VAS score was estimated at 84 14. Pain/discomfort and anxiety/depression were the two EQ-5D-5L dimensions associated with the poorer outcomes. Subgroup analyses revealed significantly higher utilities (using the EQ-5D-5L) for men than for women (0.88 vs. 0.76; P ¼ 0.002) and lower utilities for patients with severe HIV (0.83 for CD4 o 200 vs. 0.87 for CD4 Z 500; P ¼ 0.024). Conclusions: The HRQOL scores of patients with HIV/AIDS receiving antiretroviral therapy were relatively high in Bogotá, Colombia, using the EuroQol questionnaire. The utility data could be useful, in combination with cost data, for future economic evaluations